Promising mRNA vaccine technology in combating infectious disease: a boon to futuristic game changer in medical science

This is the authors' abstract. We don't add key points for this paper.

In recent years, mRNA vaccines have emerged as a groundbreaking technology in the field of infectious disease prevention and providing a promising means of battling against the diverse range of pathogens [1].The year 2023 witnessed the applauding cheer in the history of mRNA vaccines, when Nobel Prize for Physiology and Medicine was awarded to Drew Weissman and Katalin Kariko for their successful launching of mRNA vaccine against .This editorial briefly explores the principles, developments in technology, and policy implications related to mRNA vaccines.Recent technological refinements have improved mRNA transport and stability by, resolving early issues including immunogenicity and degradation, supporting the safety and effectiveness of these vaccinations.